- Home
- SUUN vs ANEB Comparison
SUUN vs ANEB Comparison
Compare SUUN & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUUN | ANEB |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.3M | 46.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SUUN | ANEB |
|---|---|---|
| Price | $1.54 | $1.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 147.2K |
| Earning Date | 02-13-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $32,753,484.00 | N/A |
| Revenue This Year | $127.67 | N/A |
| Revenue Next Year | $4.98 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.23 | $0.90 |
| 52 Week High | $6.43 | $3.42 |
Technical Indicators
Market Signals| Indicator | SUUN | ANEB |
|---|---|---|
| Relative Strength Index (RSI) | 45.99 | 29.36 |
| Support Level | $1.45 | $1.01 |
| Resistance Level | $1.75 | $1.13 |
| Average True Range (ATR) | 0.17 | 0.09 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 16.03 | 59.29 |
Price Performance
Historical ComparisonAbout SUUN SolarBank Corporation
PowerBank Corp is an independent renewable and clean energy project developer, power producer, and asset operator in Canada and the United States, with the majority of its revenue coming from the United States. The Company operates through two reportable segments: Development and EPC, which involves the development and construction of solar photovoltaic power projects, and IPP Production, which includes the operation of solar power and battery energy storage systems. Corporate and other activities cover operation, maintenance, and repairs. The majority of revenue is generated from the Development and EPC segment.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.